drugdeliverybusiness42m
Fractyl Health announces layoffs as it pivots to gene therapy
Fractyl Health (Nasdaq:GUTS) is cutting nearly a fifth of its workforce as it streamlines resources and shifts focus toward ...
drugdeliverybusiness3h
Modular Medical takes step forward in CE mark process for insulin pump tech
Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...
drugdeliverybusiness1d
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
drugdeliverybusiness10d
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
drugdeliverybusiness3d
Beta Bionics goes public with upsized $204M IPO
Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering ...
drugdeliverybusiness12d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
drugdeliverybusiness3d
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).
drugdeliverybusiness12d
Initial Public Offering (IPO)
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO). Earlier this month, the maker of the iLet bionic pancreas filed a registration ...